| Pradeepa Selvakumar Md Inc, A California Professional Corporation | |
|
101 S San Mateo Dr Ste 102 San Mateo CA 94401-3840 | |
| (650) 435-8211 | |
| (844) 965-9436 |
| Full Name | Pradeepa Selvakumar Md Inc, A California Professional Corporation |
|---|---|
| Speciality | Internal Medicine |
| Location | 101 S San Mateo Dr Ste 102, San Mateo, California |
| Authorized Official Name and Position | Pradeepa Selvakumar (OWNER) |
| Authorized Official Contact | 6504358211 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Pradeepa Selvakumar Md Inc, A California Professional Corporation 2889 Baze Rd San Mateo CA 94403-3436 Ph: (415) 778-0813 | Pradeepa Selvakumar Md Inc, A California Professional Corporation 101 S San Mateo Dr Ste 102 San Mateo CA 94401-3840 Ph: (650) 435-8211 |
| NPI Number | 1013472950 |
|---|---|
| Provider Enumeration Date | 02/05/2019 |
| Last Update Date | 02/05/2019 |
| Medicare PECOS PAC ID | 0143556670 |
|---|---|
| Medicare Enrollment ID | O20190722003026 |
News Archive
Pfizer Oncology will present data from across its portfolio, including results from long-term follow-up of Aromasin® (exemestane tablets) in a study of early breast cancer, updated study results from a Phase 3 study of Sutent® (sunitinib malate) in pancreatic neuroendocrine tumors (NET), and early-stage research of investigational agents PF-02341066 and figitumumab (CP-751,871) in patients with non-small cell lung cancer (NSCLC).
Medicare reimbursement rates should be based on how cost effective the treatment is for a particular illness, according to a piece by two policy experts in the October edition of Health Affairs.
IRIDEX Corporation today announced that it has added a novel intra-ocular pressure (IOP) monitoring device called a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to IRIDEX through a distribution agreement with Icare Finland Plc, a subsidiary of the Revenio Group Corporation, the creator of the tonometer.
When Australia, India, Japan and the US — countries strategically allied under the so-called Quad (Quadrilateral Security Dialogue) — switched focus to fighting COVID-19, it was seen as one more of the several 'proxy wars' spawned by the pandemic.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013472950 | NPI | - | NPPES |
| 1912090226 | Other | CA | OTHER INSURANCES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Pradeepa Selvakumar |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1912090226 PECOS PAC ID: 0446266548 Enrollment ID: I20060227000717 |
News Archive
Pfizer Oncology will present data from across its portfolio, including results from long-term follow-up of Aromasin® (exemestane tablets) in a study of early breast cancer, updated study results from a Phase 3 study of Sutent® (sunitinib malate) in pancreatic neuroendocrine tumors (NET), and early-stage research of investigational agents PF-02341066 and figitumumab (CP-751,871) in patients with non-small cell lung cancer (NSCLC).
Medicare reimbursement rates should be based on how cost effective the treatment is for a particular illness, according to a piece by two policy experts in the October edition of Health Affairs.
IRIDEX Corporation today announced that it has added a novel intra-ocular pressure (IOP) monitoring device called a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to IRIDEX through a distribution agreement with Icare Finland Plc, a subsidiary of the Revenio Group Corporation, the creator of the tonometer.
When Australia, India, Japan and the US — countries strategically allied under the so-called Quad (Quadrilateral Security Dialogue) — switched focus to fighting COVID-19, it was seen as one more of the several 'proxy wars' spawned by the pandemic.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
› Verified 2 days ago
News Archive
Pfizer Oncology will present data from across its portfolio, including results from long-term follow-up of Aromasin® (exemestane tablets) in a study of early breast cancer, updated study results from a Phase 3 study of Sutent® (sunitinib malate) in pancreatic neuroendocrine tumors (NET), and early-stage research of investigational agents PF-02341066 and figitumumab (CP-751,871) in patients with non-small cell lung cancer (NSCLC).
Medicare reimbursement rates should be based on how cost effective the treatment is for a particular illness, according to a piece by two policy experts in the October edition of Health Affairs.
IRIDEX Corporation today announced that it has added a novel intra-ocular pressure (IOP) monitoring device called a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to IRIDEX through a distribution agreement with Icare Finland Plc, a subsidiary of the Revenio Group Corporation, the creator of the tonometer.
When Australia, India, Japan and the US — countries strategically allied under the so-called Quad (Quadrilateral Security Dialogue) — switched focus to fighting COVID-19, it was seen as one more of the several 'proxy wars' spawned by the pandemic.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
› Verified 2 days ago
San Mateo Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 W 39th Ave, San Mateo, CA 94403 Phone: 650-573-2222 | |
Gurpreet K. Padam Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 S San Mateo Dr Ste 102, San Mateo, CA 94401 Phone: 650-360-9309 | |
San Mateo Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 W 39th Ave, San Mateo, CA 94403 Phone: 650-573-3962 | |
San Mateo Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 W 39th Ave, San Mateo, CA 94403 Phone: 650-573-3602 | |
Shu Chiropractic And Associates Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 407 N San Mateo Dr, Suite 5, San Mateo, CA 94401 Phone: 415-509-6632 | |
San Mateo Medical Centerr Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 W 39th Ave, San Mateo, CA 94403 Phone: 650-573-2222 |